(ELDN) - FDA

(ELDN) – FDA

Mar 21, 2024 10:31 AM Eledon Pharmaceuticals (ELDN) Announces Use of Tegoprubart in First-ever Transplant of Genetically Modified Kidney from a Pig to a Human
Nov 2, 2023 09:06 AM Eledon Pharmaceuticals (ELDN) Reports Updated Data from Ongoing Phase 1b Trial of Tegoprubart
Sep 25, 2023 07:03 AM
May 1, 2023 07:03 AM
Mar 31, 2023 06:01 AM
Mar 23, 2023 08:03 AM
Sep 6, 2022 04:03 PM
Aug 1, 2022 05:49 AM
Jun 9, 2022 08:03 AM
May 31, 2022 06:09 AM
Apr 26, 2021 04:26 PM